Search Results - "Matos AI"

Bibliometric analysis of research trends on nanotechnology applications in atherosclerosis.

Authors: Zhang, Xiaoshan Ji, Bo Liu, Zheng et al.

Source: Discover Nano; 7/2/2026, Vol. 21 Issue 1, p1-21, 21p

Ligand decorated nanostructure carrier systems for targeted delivery of antimalarials.

Authors: Singh, Kuldeep Ranjha, Ritesh Malla, Waseem Akram et al.

Source: Discover Nano; 6/1/2026, Vol. 21 Issue 1, p1-22, 22p

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Authors: Carreira B Acúrcio RC Matos AI et al.

Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Nov 10; Vol. 387, pp. 114178. Date of Electronic Publication: 2025 Aug 29.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

Poly(2-oxazoline)s: a versatile polymers shaping the future of biomedical innovations.

Authors: Shinde, Snehal Dargude, Shrikant Gholap, Amol D. et al.

Source: Discover Chemistry. 5/20/2026, Vol. 3 Issue 1, p1-39. 39p.

Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment.

Authors: Arjmand, Babak Alavi-Moghadam, Sepideh Khorsand, Golnar et al.

Source: Regenerative Engineering & Translational Medicine. Dec2024, Vol. 10 Issue 4, p480-499. 20p.

Comprehensive insights into mechanism of nanotoxicity, assessment methods and regulatory challenges of nanomedicines.

Authors: Havelikar, Ujwal Ghorpade, Kabirdas B. Kumar, Amit et al.

Source: Discover Nano; 10/4/2024, Vol. 19 Issue 1, p1-36, 36p

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy.

Authors: Peres C Matos AI Carreira B et al.

Source: Advanced functional materials [Adv Funct Mater] 2024 Aug 14; Vol. 34 (33), pp. 2401749. Date of Electronic Publication: 2024 Apr 01.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101190390 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1616-301X (Print) Linking ISSN: 1616301X NLM ISO Abbreviation: Adv Funct Mater Subsets: PubMed not MEDLINE

Advances in biomedical applications of Sebased nanozymes.

Authors: Feng, Yanping Chen, JinYi Ning, Congqin

Source: Journal of Nanobiotechnology. 11/11/2025, Vol. 23 Issue 1, p1-42. 42p. 8 Color Photographs, 5 Diagrams, 3 Charts, 9 Graphs.

In silico and in vivo toxicity assessment of cysteamine-modified nanoparticles: implications for pharmacotherapy application.

Authors: Alabi, Babatunde Lawal, Sodiq Kolawole Olojede, Samuel Oluwaseun et al.

Source: Toxicology Mechanisms & Methods. Nov2025, Vol. 35 Issue 9, p1400-1418. 19p.

Recent advances in lipid and biomimetic nanocarriers for nucleic acid delivery in glioblastoma.

Authors: Xu C He Z Li J

Source: Discover oncology [Discov Oncol] 2026 Apr 20; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

Enhanced mRNA vaccine combined with immune checkpoint blockade efficiently suppresses tumor growth and metastasis.

Authors: Zhang Y Ma X Jin D et al.

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2026 Apr 07; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 07.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Mucoadhesive nanofibers for ocular drug delivery: mechanisms, design strategies, and applications.

Authors: Desai N Colley HE Krishna Y et al.

Source: Drug delivery and translational research [Drug Deliv Transl Res] 2026 Apr; Vol. 16 (4), pp. 1096-1135. Date of Electronic Publication: 2025 Jun 25.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE; In Process

Targeting metalloptosis in tumor therapy: from molecular mechanisms to application of metal nanoparticles.

Authors: Wang, Jinxiang Tian, Qin Liu, Yuchen et al.

Source: Molecular Cancer. 10/16/2025, Vol. 24 Issue 1, p1-61. 61p.

The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets.

Authors: Zhang, Chunyu Guo, Xiangdong Wang, Yanan et al.

Source: Molecular Cancer. 9/30/2025, Vol. 24 Issue 1, p1-38. 38p.

Nutritional Strategies in Oncology: A Narrative Review of Advances in Folate-Targeted Therapeutic Approaches for Cancer Treatment.

Authors: Saraei, Pouya Ghasemi, Morteza Talebi, Athar et al.

Source: Nutrition & Cancer. 2025, Vol. 77 Issue 7/8, p737-759. 23p.

Stimuli‐accelerated polymeric drug delivery systems.

Authors: Rust, Tarik Jung, Dimitri Langer, Klaus et al.

Source: Polymer International. Jan2023, Vol. 72 Issue 1, p5-19. 15p.

Nanoparticle-based theranostics in nuclear medicine.

Authors: Uinarni, Herlina Kadhum, Wesam R. Saleh, Raed Obaid et al.

Source: Journal of Radioanalytical & Nuclear Chemistry. Apr2024, Vol. 333 Issue 4, p1661-1672. 12p.

Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting.

Authors: Wang R Chen Y Fang YF

Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 Jul 09. Date of Electronic Publication: 2026 Jul 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

Double-coated PLGA nanoparticles with hierarchical surface architecture for CD44-targeted siRNA delivery.

Authors: Longobardi G Shekhter P Conte C et al.

Source: Drug delivery and translational research [Drug Deliv Transl Res] 2026 May 08. Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE

Nanobiotechnology: traditional re-interpreting personalized medicine through targeted therapies and regenerative solutions.

Authors: Chattopadhyay S Goswami A Sil M

Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Aug; Vol. 398 (8), pp. 10025-10048. Date of Electronic Publication: 2025 Mar 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE